Figure 3.

NG2/CSPG4-antibody immunotherapy inhibits tumor growth in human undifferentiated pleomorphic sarcoma xenografts. A, NG2/CSPG4-antibody treatments resulted in a decrease in tumor weight when compared with tumors treated with IgG; n = 10 in each group. B, antibody treatment decreased tumor cell proliferation; n = 6 in each group. C, antibody treatment increased tumor cell apoptosis; n = 6 in each group. Data are shown as means with 95% confidence intervals indicated (error bars). *, p < 0.05.